Evercore Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Evercore Wealth Management's MRNA Position: Q3 2026 in Review
Evercore Wealth Management opened a new position in Moderna (MRNA) in Q3 2026: 2,235 shares worth $430K. The stake represents 0.01% of the portfolio and ranks #302 among its holdings. This is a return to the name: Evercore Wealth Management previously reported a position in MRNA as recently as Q4 2022.
Evercore Wealth Management first reported a position in MRNA in Q2 2021 and has held it in 6 quarters since. The position peaked at $477K in Q3 2021. 1,044 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Evercore Wealth Management held 2,235 shares of Moderna worth $430K as of Q3 2026.
- Moderna was a new Evercore Wealth Management position in Q3 2026.
- Moderna made up 0.01% of Evercore Wealth Management's portfolio in Q3 2026, its #302 holding.
- Evercore Wealth Management first reported a position in Moderna in Q2 2021 and has held it in 6 quarters since.
- Evercore Wealth Management's Moderna position peaked at $477K in Q3 2021.
- 1,044 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Evercore Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.